Log In
BCIQ
Print this Print this
 

PDR001

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionAnti-PD1 checkpoint inhibitor
Molecular Target Protectin D1 (PD1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today